| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/19/2004 | CN1149971C Cosmetic or pharmaceutical compositions consisting of liposomes, its preparation method and use |
| 05/19/2004 | CN1149929C Direct actional anti-fungus agent |
| 05/18/2004 | US6737463 Barium ferrite filler; magnetic tapes |
| 05/18/2004 | US6737427 Administering to the patient suffering with the disease caused by overproduction of mucin such as chronic obstructive pulmonary diseases including asthma, emphysema, and chronic bronchitis a mucin glycoprotein synthesis inhibitor |
| 05/18/2004 | US6737419 Stability |
| 05/18/2004 | US6737414 Composition for enteral nutrition comprising fibres |
| 05/18/2004 | US6737401 Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom |
| 05/18/2004 | US6737101 Spray-coated pharmaceutical powder compositions for transdermal administration using a needleless syringe |
| 05/18/2004 | US6737087 Composition containing Asiasari Radix extracts for protecting brain cells and improving memory |
| 05/18/2004 | US6737082 Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method |
| 05/18/2004 | US6737081 Melt congealing allotropic compound formulation into plurality of particles of uniform shape, exposing microspheres to atmosphere saturated with vapors of solvent for compound to effect solid state crystallization, recovering particles |
| 05/18/2004 | US6737080 Laminate comprising first moisture sensitive layer including moisture sensitive component, and second moisture absorbing layer including activated desiccant; spatial separation of layers prevents components from moving between layers |
| 05/18/2004 | US6737079 For burns, injuries of skin; lyases enzyme on carrier |
| 05/18/2004 | US6737077 Proteinaceous animal chew with dentally therapeutic cation |
| 05/18/2004 | US6737074 Cells in a culture medium bind to fibrin microbeads which are biologically active and comprise very crosslinked fibrin(ogen); transplanting; engineering tissue by applying to a prosthesis; separating cells; wound healing agents |
| 05/18/2004 | US6737068 Wipe formulation |
| 05/18/2004 | US6737045 Methods and compositions for the pulmonary delivery insulin |
| 05/18/2004 | US6737044 Aerosol composition |
| 05/18/2004 | US6737043 Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route |
| 05/18/2004 | US6737042 Delivery of drug esters through an inhalation route |
| 05/18/2004 | US6737041 Non-ozone depleting vapocoolants |
| 05/18/2004 | US6737005 Method of producing solid dosage forms |
| 05/18/2004 | CA2282427C Controlled release of pharmaceuticals in the anterior chamber of the eye |
| 05/18/2004 | CA2252310C Glucoamylase converted starch derivatives and their use as emulsifying and encapsulating agents |
| 05/18/2004 | CA2248139C Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| 05/18/2004 | CA2159485C Anti-oxydant alkylaryl polyether alcohol polymers |
| 05/18/2004 | CA2090911C Aqueous pharmaceutical formulations of sodium cromoglycate |
| 05/18/2004 | CA2076010C Microspheres, preparation process and use thereof |
| 05/13/2004 | WO2004039817A1 Cardiolipin molecules and method of synthesis |
| 05/13/2004 | WO2004039454A1 Formulations containing melatonin, ginkgo biloba, and biotin |
| 05/13/2004 | WO2004039430A2 Method of treating insulin resistance, adult onset diabetes and metabolic syndrome x |
| 05/13/2004 | WO2004039428A2 Transdermal delivery system for dried particulate or lyophilized medications |
| 05/13/2004 | WO2004039427A2 Transdermal delivery system for anti-emetic medication |
| 05/13/2004 | WO2004039426A2 Transdermal delivery system for water insoluble drugs |
| 05/13/2004 | WO2004039406A1 Medicinal preparation having chemotherapeutic encapsulated therein |
| 05/13/2004 | WO2004039392A2 Stabilized, solid-state polypeptide particles |
| 05/13/2004 | WO2004039390A1 Ointment composition for treating decubitus ulcers and methods for its making and its use |
| 05/13/2004 | WO2004039369A1 Daily melatonin dosing units |
| 05/13/2004 | WO2004039363A1 Anti-cancer composition comprising dmxaa or related compound |
| 05/13/2004 | WO2004039361A1 Pulsatile release compositions of milnacipran |
| 05/13/2004 | WO2004039360A1 Aqueous 2,6-diisopropylphenol pharmaceutical compositions |
| 05/13/2004 | WO2004039358A1 Adhesive composition for dermal patch and production process thereof |
| 05/13/2004 | WO2004039357A1 Multilayer dosage forms, which contain active substances and which comprise a neutral core, and an inner and outer coating consisting of methacrylate copolymers and methacrylate monomers |
| 05/13/2004 | WO2004039356A1 A method for normalizing insulin levels |
| 05/13/2004 | WO2004039355A1 Therapeutic compositions |
| 05/13/2004 | WO2004039352A2 Amorphous form of losartan potassium |
| 05/13/2004 | WO2004039351A2 Pharmaceutical compositions suitable for the treatment of ophthalmic diseases |
| 05/13/2004 | WO2004039350A1 Nasal stick for the applocation of medicaments and skin care substances |
| 05/13/2004 | WO2004039349A1 Pharmaceutical and cosmetic formulations |
| 05/13/2004 | WO2004039348A1 Formulations for topical delivery of bioactive substances and methods for their use |
| 05/13/2004 | WO2004039323A2 Fast curing compositions |
| 05/13/2004 | WO2004039320A2 STEREOISOMERS OF p-HYDROXY-MILNACIPRAN, AND METHODS OF USE THEREOF |
| 05/13/2004 | WO2004039315A2 Method for treating wounds to promote healing |
| 05/13/2004 | WO2004039295A1 Methods and devices usable in eye surgery |
| 05/13/2004 | WO2004032898A3 Controlled release system containing sucrose acetate isobutyrate |
| 05/13/2004 | WO2004030623A3 Nitroxide radioprotector formulations and methods of use |
| 05/13/2004 | WO2004017943A3 Non-vesicular cationic lipid formulations |
| 05/13/2004 | WO2004017938A3 Nitrofurantoin controlled release dosage form |
| 05/13/2004 | WO2004014335A3 Dual-spike release formulation for oral drug delivery |
| 05/13/2004 | WO2004009085A3 Taste masked sumatriptan tablets and processes for their preparation |
| 05/13/2004 | WO2004006990A3 Medical device and method for tissue removal and repair |
| 05/13/2004 | WO2004000293A3 Use of taurine or derivatives thereof for the treatment of alopecia |
| 05/13/2004 | WO2003103637A3 Modified release, multiple unit drug delivery systems |
| 05/13/2004 | WO2003094888A9 Processes for forming a drug delivery device |
| 05/13/2004 | WO2003090684B1 Polymer compositions containing a macrocyclic triene compound |
| 05/13/2004 | WO2003086321A3 Modified release minerals |
| 05/13/2004 | WO2003082207A3 Volume efficient controlled release dosage form |
| 05/13/2004 | WO2003080022A3 Analgesics for nasal administration |
| 05/13/2004 | WO2003070280A3 Absorption enhancing agent |
| 05/13/2004 | WO2003059194A3 Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs |
| 05/13/2004 | WO2003051454A3 Methods for particle-assisted polynucleotide immunization using a pulsed electric field |
| 05/13/2004 | WO2003037405A9 Impedance sensor |
| 05/13/2004 | WO2003037337A8 Depot formulations of iloperidone and a star polymer |
| 05/13/2004 | WO2003037291A8 Cream for treatment of skin injured by the sun |
| 05/13/2004 | WO2003035000A3 Method for treating non-neuropathic pain |
| 05/13/2004 | WO2003032959A9 Nanoparticulate compositions comprising inorganic cores |
| 05/13/2004 | WO2002085447A8 Microprojection array having a beneficial agent containing coating |
| 05/13/2004 | WO2002072073A3 Pharmaceutical formulation comprising atorvastatin calcium |
| 05/13/2004 | WO2002051387A8 Thermoformable solid pharmaceutical composition for controlled release of ivabradine |
| 05/13/2004 | WO2002038171A9 METHODS FOR TREATING DISEASES CAUSED BY DEFICIENCIES OF α-L-IDURONIDASE |
| 05/13/2004 | WO2002030397A9 Liposomes encapsulating anticancer drugs and the use thereof in the treatment of malignant tumors |
| 05/13/2004 | WO2002024146A9 Methods of decreasing or preventing pain using spicamycin derivatives |
| 05/13/2004 | US20040092911 Ophthalmic drug delivery device |
| 05/13/2004 | US20040092865 Transcutaneous delivery means |
| 05/13/2004 | US20040092727 Cochleates without metal cations as bridging agents |
| 05/13/2004 | US20040092605 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide |
| 05/13/2004 | US20040092601 Sustained released form |
| 05/13/2004 | US20040092597 Fenofibrate compositions having high bioavailability |
| 05/13/2004 | US20040092592 Mixture of arginine, magnesium salt of 2-amino-5-guanidinovaleric acid and anticoagulant; antideposit agent for arteries plaque; cardiovascular disorders |
| 05/13/2004 | US20040092587 Freeze-dried preparation of n[o-(p-pivaloyloxybenzenesulfonylamino) benzoyl] glycine monosodium salt tetrahydrate and process for producing the same |
| 05/13/2004 | US20040092577 In situ insertion of paclitaxel; powder regenerated as injection |
| 05/13/2004 | US20040092563 Angiotensin II antagonists |
| 05/13/2004 | US20040092548 Bioavailability; liquid stream of drops; supplying to eyes |
| 05/13/2004 | US20040092544 Synergistic mixture containing dopamine agent; muscular disorders; analgesics |
| 05/13/2004 | US20040092542 Tamper-resistant oral opioid agonist formulations |
| 05/13/2004 | US20040092534 Orally administering a capsule shaped tablet core dosage form containing paliperidone, releases paliperidone an ascending release rate form a prolonged period of time |
| 05/13/2004 | US20040092531 Active substance combination containing an opioid having a fentanyl-type structure and ketamine |
| 05/13/2004 | US20040092494 Method of increasing testosterone and related steroid concentrations in women |
| 05/13/2004 | US20040092493 Method for ameliorating male erectile dysfunction |
| 05/13/2004 | US20040092481 Eating disorders; irritable bowel disorders; headaches; obsessive compulsive disorders |